Related Experiment Video

Updated: Jul 10, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors

Richard W Martin1, Brian J Orelli, Mitsuyoshi Yamazoe

  • 1Department of Radiation, Ludwig Center for Metastasis Research, University of Chicago, Chicago, Illinois 60637, USA.

Cancer Research
|October 19, 2007
PubMed

Insights

Overexpression of RAD51 in BRCA1-deficient cells rescues defects and suggests enhanced homologous recombination (HR) activity contributes to breast cancer development.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • The breast cancer susceptibility gene BRCA1 is crucial for cellular processes, but the drivers of BRCA1-deficient tumors are not fully understood.
  • BRCA1 deficiency impairs cell proliferation, and suppressor mutations may influence tumor development.

Purpose of the Study:

  • To investigate the role of homologous recombination (HR) and RAD51 in BRCA1-deficient tumorigenesis.
  • To explore potential therapeutic targets by understanding the mechanisms underlying BRCA1-deficient cancers.

Main Methods:

  • Utilized a DT40 BRCA1Δ/Δ mutant cell line to study the effects of RAD51 overexpression.
  • Performed epistasis analysis with BRCA1 and KU70 to understand DNA double-strand break repair pathways.
  • Conducted cell synchronization studies to determine the cell cycle-specific role of BRCA1 in radioresistance.
  • Analyzed microarray expression data from breast tumors.

Main Results:

  • RAD51 overexpression rescued proliferation, DNA damage survival, and HR defects in BRCA1-deficient cells.
  • BRCA1 and KU70 function independently in double-strand break repair.
  • BRCA1's radioresistance function is specific to late S and G2 cell cycle phases, consistent with homology-mediated repair.
  • Elevated RAD51, RAD54, and RAD51AP1 expression was observed in BRCA1-deficient tumors compared to sporadic tumors.

Conclusions:

  • Upregulation of homologous recombination (HR) provides a compensatory mechanism in BRCA1-deficient cells by bypassing BRCA1's role in RAD51 assembly.
  • Enhanced HR activity is implicated as a contributing factor to the development of BRCA1-deficient breast tumors.
  • These findings suggest that targeting HR pathways could be a strategy for treating BRCA1-deficient cancers.

More Related Videos

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...